Global Drug Addiction Treatment Market

Drug Addiction Treatment Comprehensive Study by Type (Methadone, Buprenorphine, Naltrexone, Bupropion, Varenicline, Others), Application (Hospitals, Clinics), Addiction Type (Opioid Addiction, Tobacco/Nicotine Addiction, Alcohol Dependence), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Treatment Centers (Outpatient Treatment Centers, Residential Treatment Centers, Inpatient Treatment Centers) Players and Region - Global Market Outlook to 2028

Drug Addiction Treatment Market by XX Submarkets | Forecast Years 2023-2028 | CAGR: 7.7%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Drug Addiction Treatment
According to the Drug report of 2016, Drug addiction is widespread globally with around 247 million drug users. Moreover, from 1999 to 2015, there are approximately 183,000 people have died in the United States reportedly due to drug overdose or related substances such as opioids. Drug addiction is a complex neurobiological disease that demands an integrated treatment of the mind, body, and spirit. It is considered as a brain disease because drugs change the brain they change its structure and how it works. Without treatment, these brain changes can last long. Further increasing number of youngsters getting affectionate with an urge to experience these drug addiction and growing healthcare infrastructure is anticipated to drive the market growth.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Billion)
CAGR7.7%


The global drug addiction treatment market is fairly competitive and consists of various emerging and well-established major companies. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Drug Addiction Treatment market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Indivior (United Kingdom), Pfizer, Inc. (United States), Alkermes (Ireland), Novartis International AG (Switzerland), Mylan N.V. (United States), Cipla (India), Glenmark (India) and British American Tobacco plc (United Kingdom) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Dr. Reddy's Laboratories (India), Teva Pharmaceuticals (Israel), PLIVA (Odyssey) (United States) and Lil Drug Store plc (United States).

Segmentation Overview
AMA Research has segmented the market of Global Drug Addiction Treatment market by Type (Methadone, Buprenorphine, Naltrexone, Bupropion, Varenicline and Others), Application (Hospitals and Clinics) and Region.



On the basis of geography, the market of Drug Addiction Treatment has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Addiction Type, the sub-segment i.e. Opioid Addiction will boost the Drug Addiction Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Distribution Channel, the sub-segment i.e. Hospital Pharmacy will boost the Drug Addiction Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Treatment Centers, the sub-segment i.e. Outpatient Treatment Centers will boost the Drug Addiction Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Launch and Approval of Novel Drug for the Treatment, Increasing Number of Death cases due to Drug Abuse and Encouragement by the Government As Well As Rehabilitation Centers to Control Drug Addiction

Market Growth Drivers:
Rising Awareness among People about the Adverse Effects of Drug Addiction through Social Media, Increasing Number of Rehabilitation center in Developed and under Developed Countries and The Surge in the Number of Youngsters Getting Addicted to Alcohol, Tobacco, etc.

Challenges:
Stringent Government Policies Related to Drugs under Pipeline for Addiction Treatment.

Restraints:
High Cost of Drug Addiction Treatment may hamper the Market Growth

Opportunities:
Stringent Laws by the Government Due to Rising Prevalence of Drug Addiction and High Investment in Healthcare Sector and Rising R & D activities

Market Leaders and their expansionary development strategies
In January 2019 Center on Addiction and Partnership for Drug-Free Kids announced they are merging under the name Center on Addiction. As mortalities are on the peak from drug overdoses, the organizations are uniting to accelerate progress against this deadly disease and transform how the nation addresses addiction.
In April 2022, Indivior PLC (LON: INDV) today presented an integrated analysis of three clinical Phase III studies evaluating the additional benefits of long-term treatment with SUBLOCADE® (buprenorphine extended-release) injections for up to 18 months in treatment-seeking adults with moderate or severe opioid use disorder (OUD).1 The data will be presented at the American Society of Addiction Medicine (ASAM) 2022 Annual Meeting, taking place from March 31st to April 3rd, 2022
The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act of 2018, was made law to address the nation’s opioid overdose epidemic. and The legislation includes provisions to strengthen the behavioral health workforce through increasing addiction medicine education; standardize the delivery of addiction medicine; expand access to high-quality, evidence-based care; and cover addiction medicine in a way that facilitates the delivery of coordinated and comprehensive treatment.

Key Target Audience
Pharmaceutical Companies, Traders/Distributors & Suppliers, Industry Associations, Potential Investors, Government & Regulatory Bodies and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Methadone
  • Buprenorphine
  • Naltrexone
  • Bupropion
  • Varenicline
  • Others
By Application
  • Hospitals
  • Clinics
By Addiction Type
  • Opioid Addiction
  • Tobacco/Nicotine Addiction
  • Alcohol Dependence

By Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Treatment Centers
  • Outpatient Treatment Centers
  • Residential Treatment Centers
  • Inpatient Treatment Centers

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Awareness among People about the Adverse Effects of Drug Addiction through Social Media
      • 3.2.2. Increasing Number of Rehabilitation center in Developed and under Developed Countries
      • 3.2.3. The Surge in the Number of Youngsters Getting Addicted to Alcohol, Tobacco, etc.
    • 3.3. Market Challenges
      • 3.3.1. Stringent Government Policies Related to Drugs under Pipeline for Addiction Treatment.
    • 3.4. Market Trends
      • 3.4.1. Launch and Approval of Novel Drug for the Treatment
      • 3.4.2. Increasing Number of Death cases due to Drug Abuse
      • 3.4.3. Encouragement by the Government As Well As Rehabilitation Centers to Control Drug Addiction
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Drug Addiction Treatment, by Type, Application, Addiction Type, Distribution Channel, Treatment Centers and Region (value, volume and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Drug Addiction Treatment (Value)
      • 5.2.1. Global Drug Addiction Treatment by: Type (Value)
        • 5.2.1.1. Methadone
        • 5.2.1.2. Buprenorphine
        • 5.2.1.3. Naltrexone
        • 5.2.1.4. Bupropion
        • 5.2.1.5. Varenicline
        • 5.2.1.6. Others
      • 5.2.2. Global Drug Addiction Treatment by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Clinics
      • 5.2.3. Global Drug Addiction Treatment by: Addiction Type (Value)
        • 5.2.3.1. Opioid Addiction
        • 5.2.3.2. Tobacco/Nicotine Addiction
        • 5.2.3.3. Alcohol Dependence
      • 5.2.4. Global Drug Addiction Treatment by: Distribution Channel (Value)
        • 5.2.4.1. Hospital Pharmacy
        • 5.2.4.2. Retail Pharmacy
        • 5.2.4.3. Online Pharmacy
      • 5.2.5. Global Drug Addiction Treatment by: Treatment Centers (Value)
        • 5.2.5.1. Outpatient Treatment Centers
        • 5.2.5.2. Residential Treatment Centers
        • 5.2.5.3. Inpatient Treatment Centers
      • 5.2.6. Global Drug Addiction Treatment Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Drug Addiction Treatment (Volume)
      • 5.3.1. Global Drug Addiction Treatment by: Type (Volume)
        • 5.3.1.1. Methadone
        • 5.3.1.2. Buprenorphine
        • 5.3.1.3. Naltrexone
        • 5.3.1.4. Bupropion
        • 5.3.1.5. Varenicline
        • 5.3.1.6. Others
      • 5.3.2. Global Drug Addiction Treatment by: Application (Volume)
        • 5.3.2.1. Hospitals
        • 5.3.2.2. Clinics
      • 5.3.3. Global Drug Addiction Treatment by: Addiction Type (Volume)
        • 5.3.3.1. Opioid Addiction
        • 5.3.3.2. Tobacco/Nicotine Addiction
        • 5.3.3.3. Alcohol Dependence
      • 5.3.4. Global Drug Addiction Treatment by: Distribution Channel (Volume)
        • 5.3.4.1. Hospital Pharmacy
        • 5.3.4.2. Retail Pharmacy
        • 5.3.4.3. Online Pharmacy
      • 5.3.5. Global Drug Addiction Treatment by: Treatment Centers (Volume)
        • 5.3.5.1. Outpatient Treatment Centers
        • 5.3.5.2. Residential Treatment Centers
        • 5.3.5.3. Inpatient Treatment Centers
      • 5.3.6. Global Drug Addiction Treatment Region
        • 5.3.6.1. South America
          • 5.3.6.1.1. Brazil
          • 5.3.6.1.2. Argentina
          • 5.3.6.1.3. Rest of South America
        • 5.3.6.2. Asia Pacific
          • 5.3.6.2.1. China
          • 5.3.6.2.2. Japan
          • 5.3.6.2.3. India
          • 5.3.6.2.4. South Korea
          • 5.3.6.2.5. Taiwan
          • 5.3.6.2.6. Australia
          • 5.3.6.2.7. Rest of Asia-Pacific
        • 5.3.6.3. Europe
          • 5.3.6.3.1. Germany
          • 5.3.6.3.2. France
          • 5.3.6.3.3. Italy
          • 5.3.6.3.4. United Kingdom
          • 5.3.6.3.5. Netherlands
          • 5.3.6.3.6. Rest of Europe
        • 5.3.6.4. MEA
          • 5.3.6.4.1. Middle East
          • 5.3.6.4.2. Africa
        • 5.3.6.5. North America
          • 5.3.6.5.1. United States
          • 5.3.6.5.2. Canada
          • 5.3.6.5.3. Mexico
    • 5.4. Global Drug Addiction Treatment (Price)
      • 5.4.1. Global Drug Addiction Treatment by: Type (Price)
  • 6. Drug Addiction Treatment: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Indivior (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Pfizer, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Alkermes (Ireland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Novartis International AG (Switzerland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Mylan N.V. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Cipla (India)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Glenmark (India)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. British American Tobacco plc (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Drug Addiction Treatment Sale, by Type, Application, Addiction Type, Distribution Channel, Treatment Centers and Region (value, volume and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Drug Addiction Treatment (Value)
      • 7.2.1. Global Drug Addiction Treatment by: Type (Value)
        • 7.2.1.1. Methadone
        • 7.2.1.2. Buprenorphine
        • 7.2.1.3. Naltrexone
        • 7.2.1.4. Bupropion
        • 7.2.1.5. Varenicline
        • 7.2.1.6. Others
      • 7.2.2. Global Drug Addiction Treatment by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Clinics
      • 7.2.3. Global Drug Addiction Treatment by: Addiction Type (Value)
        • 7.2.3.1. Opioid Addiction
        • 7.2.3.2. Tobacco/Nicotine Addiction
        • 7.2.3.3. Alcohol Dependence
      • 7.2.4. Global Drug Addiction Treatment by: Distribution Channel (Value)
        • 7.2.4.1. Hospital Pharmacy
        • 7.2.4.2. Retail Pharmacy
        • 7.2.4.3. Online Pharmacy
      • 7.2.5. Global Drug Addiction Treatment by: Treatment Centers (Value)
        • 7.2.5.1. Outpatient Treatment Centers
        • 7.2.5.2. Residential Treatment Centers
        • 7.2.5.3. Inpatient Treatment Centers
      • 7.2.6. Global Drug Addiction Treatment Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Drug Addiction Treatment (Volume)
      • 7.3.1. Global Drug Addiction Treatment by: Type (Volume)
        • 7.3.1.1. Methadone
        • 7.3.1.2. Buprenorphine
        • 7.3.1.3. Naltrexone
        • 7.3.1.4. Bupropion
        • 7.3.1.5. Varenicline
        • 7.3.1.6. Others
      • 7.3.2. Global Drug Addiction Treatment by: Application (Volume)
        • 7.3.2.1. Hospitals
        • 7.3.2.2. Clinics
      • 7.3.3. Global Drug Addiction Treatment by: Addiction Type (Volume)
        • 7.3.3.1. Opioid Addiction
        • 7.3.3.2. Tobacco/Nicotine Addiction
        • 7.3.3.3. Alcohol Dependence
      • 7.3.4. Global Drug Addiction Treatment by: Distribution Channel (Volume)
        • 7.3.4.1. Hospital Pharmacy
        • 7.3.4.2. Retail Pharmacy
        • 7.3.4.3. Online Pharmacy
      • 7.3.5. Global Drug Addiction Treatment by: Treatment Centers (Volume)
        • 7.3.5.1. Outpatient Treatment Centers
        • 7.3.5.2. Residential Treatment Centers
        • 7.3.5.3. Inpatient Treatment Centers
      • 7.3.6. Global Drug Addiction Treatment Region
        • 7.3.6.1. South America
          • 7.3.6.1.1. Brazil
          • 7.3.6.1.2. Argentina
          • 7.3.6.1.3. Rest of South America
        • 7.3.6.2. Asia Pacific
          • 7.3.6.2.1. China
          • 7.3.6.2.2. Japan
          • 7.3.6.2.3. India
          • 7.3.6.2.4. South Korea
          • 7.3.6.2.5. Taiwan
          • 7.3.6.2.6. Australia
          • 7.3.6.2.7. Rest of Asia-Pacific
        • 7.3.6.3. Europe
          • 7.3.6.3.1. Germany
          • 7.3.6.3.2. France
          • 7.3.6.3.3. Italy
          • 7.3.6.3.4. United Kingdom
          • 7.3.6.3.5. Netherlands
          • 7.3.6.3.6. Rest of Europe
        • 7.3.6.4. MEA
          • 7.3.6.4.1. Middle East
          • 7.3.6.4.2. Africa
        • 7.3.6.5. North America
          • 7.3.6.5.1. United States
          • 7.3.6.5.2. Canada
          • 7.3.6.5.3. Mexico
    • 7.4. Global Drug Addiction Treatment (Price)
      • 7.4.1. Global Drug Addiction Treatment by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Drug Addiction Treatment: by Type(USD Billion)
  • Table 2. Drug Addiction Treatment Methadone , by Region USD Billion (2017-2022)
  • Table 3. Drug Addiction Treatment Buprenorphine , by Region USD Billion (2017-2022)
  • Table 4. Drug Addiction Treatment Naltrexone , by Region USD Billion (2017-2022)
  • Table 5. Drug Addiction Treatment Bupropion , by Region USD Billion (2017-2022)
  • Table 6. Drug Addiction Treatment Varenicline , by Region USD Billion (2017-2022)
  • Table 7. Drug Addiction Treatment Others , by Region USD Billion (2017-2022)
  • Table 8. Drug Addiction Treatment: by Application(USD Billion)
  • Table 9. Drug Addiction Treatment Hospitals , by Region USD Billion (2017-2022)
  • Table 10. Drug Addiction Treatment Clinics , by Region USD Billion (2017-2022)
  • Table 11. Drug Addiction Treatment: by Addiction Type(USD Billion)
  • Table 12. Drug Addiction Treatment Opioid Addiction , by Region USD Billion (2017-2022)
  • Table 13. Drug Addiction Treatment Tobacco/Nicotine Addiction , by Region USD Billion (2017-2022)
  • Table 14. Drug Addiction Treatment Alcohol Dependence , by Region USD Billion (2017-2022)
  • Table 15. Drug Addiction Treatment: by Distribution Channel(USD Billion)
  • Table 16. Drug Addiction Treatment Hospital Pharmacy , by Region USD Billion (2017-2022)
  • Table 17. Drug Addiction Treatment Retail Pharmacy , by Region USD Billion (2017-2022)
  • Table 18. Drug Addiction Treatment Online Pharmacy , by Region USD Billion (2017-2022)
  • Table 19. Drug Addiction Treatment: by Treatment Centers(USD Billion)
  • Table 20. Drug Addiction Treatment Outpatient Treatment Centers , by Region USD Billion (2017-2022)
  • Table 21. Drug Addiction Treatment Residential Treatment Centers , by Region USD Billion (2017-2022)
  • Table 22. Drug Addiction Treatment Inpatient Treatment Centers , by Region USD Billion (2017-2022)
  • Table 23. South America Drug Addiction Treatment, by Country USD Billion (2017-2022)
  • Table 24. South America Drug Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 25. South America Drug Addiction Treatment, by Application USD Billion (2017-2022)
  • Table 26. South America Drug Addiction Treatment, by Addiction Type USD Billion (2017-2022)
  • Table 27. South America Drug Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 28. South America Drug Addiction Treatment, by Treatment Centers USD Billion (2017-2022)
  • Table 29. Brazil Drug Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 30. Brazil Drug Addiction Treatment, by Application USD Billion (2017-2022)
  • Table 31. Brazil Drug Addiction Treatment, by Addiction Type USD Billion (2017-2022)
  • Table 32. Brazil Drug Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 33. Brazil Drug Addiction Treatment, by Treatment Centers USD Billion (2017-2022)
  • Table 34. Argentina Drug Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 35. Argentina Drug Addiction Treatment, by Application USD Billion (2017-2022)
  • Table 36. Argentina Drug Addiction Treatment, by Addiction Type USD Billion (2017-2022)
  • Table 37. Argentina Drug Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 38. Argentina Drug Addiction Treatment, by Treatment Centers USD Billion (2017-2022)
  • Table 39. Rest of South America Drug Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 40. Rest of South America Drug Addiction Treatment, by Application USD Billion (2017-2022)
  • Table 41. Rest of South America Drug Addiction Treatment, by Addiction Type USD Billion (2017-2022)
  • Table 42. Rest of South America Drug Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 43. Rest of South America Drug Addiction Treatment, by Treatment Centers USD Billion (2017-2022)
  • Table 44. Asia Pacific Drug Addiction Treatment, by Country USD Billion (2017-2022)
  • Table 45. Asia Pacific Drug Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 46. Asia Pacific Drug Addiction Treatment, by Application USD Billion (2017-2022)
  • Table 47. Asia Pacific Drug Addiction Treatment, by Addiction Type USD Billion (2017-2022)
  • Table 48. Asia Pacific Drug Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 49. Asia Pacific Drug Addiction Treatment, by Treatment Centers USD Billion (2017-2022)
  • Table 50. China Drug Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 51. China Drug Addiction Treatment, by Application USD Billion (2017-2022)
  • Table 52. China Drug Addiction Treatment, by Addiction Type USD Billion (2017-2022)
  • Table 53. China Drug Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 54. China Drug Addiction Treatment, by Treatment Centers USD Billion (2017-2022)
  • Table 55. Japan Drug Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 56. Japan Drug Addiction Treatment, by Application USD Billion (2017-2022)
  • Table 57. Japan Drug Addiction Treatment, by Addiction Type USD Billion (2017-2022)
  • Table 58. Japan Drug Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 59. Japan Drug Addiction Treatment, by Treatment Centers USD Billion (2017-2022)
  • Table 60. India Drug Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 61. India Drug Addiction Treatment, by Application USD Billion (2017-2022)
  • Table 62. India Drug Addiction Treatment, by Addiction Type USD Billion (2017-2022)
  • Table 63. India Drug Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 64. India Drug Addiction Treatment, by Treatment Centers USD Billion (2017-2022)
  • Table 65. South Korea Drug Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 66. South Korea Drug Addiction Treatment, by Application USD Billion (2017-2022)
  • Table 67. South Korea Drug Addiction Treatment, by Addiction Type USD Billion (2017-2022)
  • Table 68. South Korea Drug Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 69. South Korea Drug Addiction Treatment, by Treatment Centers USD Billion (2017-2022)
  • Table 70. Taiwan Drug Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 71. Taiwan Drug Addiction Treatment, by Application USD Billion (2017-2022)
  • Table 72. Taiwan Drug Addiction Treatment, by Addiction Type USD Billion (2017-2022)
  • Table 73. Taiwan Drug Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 74. Taiwan Drug Addiction Treatment, by Treatment Centers USD Billion (2017-2022)
  • Table 75. Australia Drug Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 76. Australia Drug Addiction Treatment, by Application USD Billion (2017-2022)
  • Table 77. Australia Drug Addiction Treatment, by Addiction Type USD Billion (2017-2022)
  • Table 78. Australia Drug Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 79. Australia Drug Addiction Treatment, by Treatment Centers USD Billion (2017-2022)
  • Table 80. Rest of Asia-Pacific Drug Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 81. Rest of Asia-Pacific Drug Addiction Treatment, by Application USD Billion (2017-2022)
  • Table 82. Rest of Asia-Pacific Drug Addiction Treatment, by Addiction Type USD Billion (2017-2022)
  • Table 83. Rest of Asia-Pacific Drug Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 84. Rest of Asia-Pacific Drug Addiction Treatment, by Treatment Centers USD Billion (2017-2022)
  • Table 85. Europe Drug Addiction Treatment, by Country USD Billion (2017-2022)
  • Table 86. Europe Drug Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 87. Europe Drug Addiction Treatment, by Application USD Billion (2017-2022)
  • Table 88. Europe Drug Addiction Treatment, by Addiction Type USD Billion (2017-2022)
  • Table 89. Europe Drug Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 90. Europe Drug Addiction Treatment, by Treatment Centers USD Billion (2017-2022)
  • Table 91. Germany Drug Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 92. Germany Drug Addiction Treatment, by Application USD Billion (2017-2022)
  • Table 93. Germany Drug Addiction Treatment, by Addiction Type USD Billion (2017-2022)
  • Table 94. Germany Drug Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 95. Germany Drug Addiction Treatment, by Treatment Centers USD Billion (2017-2022)
  • Table 96. France Drug Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 97. France Drug Addiction Treatment, by Application USD Billion (2017-2022)
  • Table 98. France Drug Addiction Treatment, by Addiction Type USD Billion (2017-2022)
  • Table 99. France Drug Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 100. France Drug Addiction Treatment, by Treatment Centers USD Billion (2017-2022)
  • Table 101. Italy Drug Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 102. Italy Drug Addiction Treatment, by Application USD Billion (2017-2022)
  • Table 103. Italy Drug Addiction Treatment, by Addiction Type USD Billion (2017-2022)
  • Table 104. Italy Drug Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 105. Italy Drug Addiction Treatment, by Treatment Centers USD Billion (2017-2022)
  • Table 106. United Kingdom Drug Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 107. United Kingdom Drug Addiction Treatment, by Application USD Billion (2017-2022)
  • Table 108. United Kingdom Drug Addiction Treatment, by Addiction Type USD Billion (2017-2022)
  • Table 109. United Kingdom Drug Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 110. United Kingdom Drug Addiction Treatment, by Treatment Centers USD Billion (2017-2022)
  • Table 111. Netherlands Drug Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 112. Netherlands Drug Addiction Treatment, by Application USD Billion (2017-2022)
  • Table 113. Netherlands Drug Addiction Treatment, by Addiction Type USD Billion (2017-2022)
  • Table 114. Netherlands Drug Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 115. Netherlands Drug Addiction Treatment, by Treatment Centers USD Billion (2017-2022)
  • Table 116. Rest of Europe Drug Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 117. Rest of Europe Drug Addiction Treatment, by Application USD Billion (2017-2022)
  • Table 118. Rest of Europe Drug Addiction Treatment, by Addiction Type USD Billion (2017-2022)
  • Table 119. Rest of Europe Drug Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 120. Rest of Europe Drug Addiction Treatment, by Treatment Centers USD Billion (2017-2022)
  • Table 121. MEA Drug Addiction Treatment, by Country USD Billion (2017-2022)
  • Table 122. MEA Drug Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 123. MEA Drug Addiction Treatment, by Application USD Billion (2017-2022)
  • Table 124. MEA Drug Addiction Treatment, by Addiction Type USD Billion (2017-2022)
  • Table 125. MEA Drug Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 126. MEA Drug Addiction Treatment, by Treatment Centers USD Billion (2017-2022)
  • Table 127. Middle East Drug Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 128. Middle East Drug Addiction Treatment, by Application USD Billion (2017-2022)
  • Table 129. Middle East Drug Addiction Treatment, by Addiction Type USD Billion (2017-2022)
  • Table 130. Middle East Drug Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 131. Middle East Drug Addiction Treatment, by Treatment Centers USD Billion (2017-2022)
  • Table 132. Africa Drug Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 133. Africa Drug Addiction Treatment, by Application USD Billion (2017-2022)
  • Table 134. Africa Drug Addiction Treatment, by Addiction Type USD Billion (2017-2022)
  • Table 135. Africa Drug Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 136. Africa Drug Addiction Treatment, by Treatment Centers USD Billion (2017-2022)
  • Table 137. North America Drug Addiction Treatment, by Country USD Billion (2017-2022)
  • Table 138. North America Drug Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 139. North America Drug Addiction Treatment, by Application USD Billion (2017-2022)
  • Table 140. North America Drug Addiction Treatment, by Addiction Type USD Billion (2017-2022)
  • Table 141. North America Drug Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 142. North America Drug Addiction Treatment, by Treatment Centers USD Billion (2017-2022)
  • Table 143. United States Drug Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 144. United States Drug Addiction Treatment, by Application USD Billion (2017-2022)
  • Table 145. United States Drug Addiction Treatment, by Addiction Type USD Billion (2017-2022)
  • Table 146. United States Drug Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 147. United States Drug Addiction Treatment, by Treatment Centers USD Billion (2017-2022)
  • Table 148. Canada Drug Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 149. Canada Drug Addiction Treatment, by Application USD Billion (2017-2022)
  • Table 150. Canada Drug Addiction Treatment, by Addiction Type USD Billion (2017-2022)
  • Table 151. Canada Drug Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 152. Canada Drug Addiction Treatment, by Treatment Centers USD Billion (2017-2022)
  • Table 153. Mexico Drug Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 154. Mexico Drug Addiction Treatment, by Application USD Billion (2017-2022)
  • Table 155. Mexico Drug Addiction Treatment, by Addiction Type USD Billion (2017-2022)
  • Table 156. Mexico Drug Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 157. Mexico Drug Addiction Treatment, by Treatment Centers USD Billion (2017-2022)
  • Table 158. Drug Addiction Treatment Sales: by Type(K Units)
  • Table 159. Drug Addiction Treatment Sales Methadone , by Region K Units (2017-2022)
  • Table 160. Drug Addiction Treatment Sales Buprenorphine , by Region K Units (2017-2022)
  • Table 161. Drug Addiction Treatment Sales Naltrexone , by Region K Units (2017-2022)
  • Table 162. Drug Addiction Treatment Sales Bupropion , by Region K Units (2017-2022)
  • Table 163. Drug Addiction Treatment Sales Varenicline , by Region K Units (2017-2022)
  • Table 164. Drug Addiction Treatment Sales Others , by Region K Units (2017-2022)
  • Table 165. Drug Addiction Treatment Sales: by Application(K Units)
  • Table 166. Drug Addiction Treatment Sales Hospitals , by Region K Units (2017-2022)
  • Table 167. Drug Addiction Treatment Sales Clinics , by Region K Units (2017-2022)
  • Table 168. Drug Addiction Treatment Sales: by Addiction Type(K Units)
  • Table 169. Drug Addiction Treatment Sales Opioid Addiction , by Region K Units (2017-2022)
  • Table 170. Drug Addiction Treatment Sales Tobacco/Nicotine Addiction , by Region K Units (2017-2022)
  • Table 171. Drug Addiction Treatment Sales Alcohol Dependence , by Region K Units (2017-2022)
  • Table 172. Drug Addiction Treatment Sales: by Distribution Channel(K Units)
  • Table 173. Drug Addiction Treatment Sales Hospital Pharmacy , by Region K Units (2017-2022)
  • Table 174. Drug Addiction Treatment Sales Retail Pharmacy , by Region K Units (2017-2022)
  • Table 175. Drug Addiction Treatment Sales Online Pharmacy , by Region K Units (2017-2022)
  • Table 176. Drug Addiction Treatment Sales: by Treatment Centers(K Units)
  • Table 177. Drug Addiction Treatment Sales Outpatient Treatment Centers , by Region K Units (2017-2022)
  • Table 178. Drug Addiction Treatment Sales Residential Treatment Centers , by Region K Units (2017-2022)
  • Table 179. Drug Addiction Treatment Sales Inpatient Treatment Centers , by Region K Units (2017-2022)
  • Table 180. South America Drug Addiction Treatment Sales, by Country K Units (2017-2022)
  • Table 181. South America Drug Addiction Treatment Sales, by Type K Units (2017-2022)
  • Table 182. South America Drug Addiction Treatment Sales, by Application K Units (2017-2022)
  • Table 183. South America Drug Addiction Treatment Sales, by Addiction Type K Units (2017-2022)
  • Table 184. South America Drug Addiction Treatment Sales, by Distribution Channel K Units (2017-2022)
  • Table 185. South America Drug Addiction Treatment Sales, by Treatment Centers K Units (2017-2022)
  • Table 186. Brazil Drug Addiction Treatment Sales, by Type K Units (2017-2022)
  • Table 187. Brazil Drug Addiction Treatment Sales, by Application K Units (2017-2022)
  • Table 188. Brazil Drug Addiction Treatment Sales, by Addiction Type K Units (2017-2022)
  • Table 189. Brazil Drug Addiction Treatment Sales, by Distribution Channel K Units (2017-2022)
  • Table 190. Brazil Drug Addiction Treatment Sales, by Treatment Centers K Units (2017-2022)
  • Table 191. Argentina Drug Addiction Treatment Sales, by Type K Units (2017-2022)
  • Table 192. Argentina Drug Addiction Treatment Sales, by Application K Units (2017-2022)
  • Table 193. Argentina Drug Addiction Treatment Sales, by Addiction Type K Units (2017-2022)
  • Table 194. Argentina Drug Addiction Treatment Sales, by Distribution Channel K Units (2017-2022)
  • Table 195. Argentina Drug Addiction Treatment Sales, by Treatment Centers K Units (2017-2022)
  • Table 196. Rest of South America Drug Addiction Treatment Sales, by Type K Units (2017-2022)
  • Table 197. Rest of South America Drug Addiction Treatment Sales, by Application K Units (2017-2022)
  • Table 198. Rest of South America Drug Addiction Treatment Sales, by Addiction Type K Units (2017-2022)
  • Table 199. Rest of South America Drug Addiction Treatment Sales, by Distribution Channel K Units (2017-2022)
  • Table 200. Rest of South America Drug Addiction Treatment Sales, by Treatment Centers K Units (2017-2022)
  • Table 201. Asia Pacific Drug Addiction Treatment Sales, by Country K Units (2017-2022)
  • Table 202. Asia Pacific Drug Addiction Treatment Sales, by Type K Units (2017-2022)
  • Table 203. Asia Pacific Drug Addiction Treatment Sales, by Application K Units (2017-2022)
  • Table 204. Asia Pacific Drug Addiction Treatment Sales, by Addiction Type K Units (2017-2022)
  • Table 205. Asia Pacific Drug Addiction Treatment Sales, by Distribution Channel K Units (2017-2022)
  • Table 206. Asia Pacific Drug Addiction Treatment Sales, by Treatment Centers K Units (2017-2022)
  • Table 207. China Drug Addiction Treatment Sales, by Type K Units (2017-2022)
  • Table 208. China Drug Addiction Treatment Sales, by Application K Units (2017-2022)
  • Table 209. China Drug Addiction Treatment Sales, by Addiction Type K Units (2017-2022)
  • Table 210. China Drug Addiction Treatment Sales, by Distribution Channel K Units (2017-2022)
  • Table 211. China Drug Addiction Treatment Sales, by Treatment Centers K Units (2017-2022)
  • Table 212. Japan Drug Addiction Treatment Sales, by Type K Units (2017-2022)
  • Table 213. Japan Drug Addiction Treatment Sales, by Application K Units (2017-2022)
  • Table 214. Japan Drug Addiction Treatment Sales, by Addiction Type K Units (2017-2022)
  • Table 215. Japan Drug Addiction Treatment Sales, by Distribution Channel K Units (2017-2022)
  • Table 216. Japan Drug Addiction Treatment Sales, by Treatment Centers K Units (2017-2022)
  • Table 217. India Drug Addiction Treatment Sales, by Type K Units (2017-2022)
  • Table 218. India Drug Addiction Treatment Sales, by Application K Units (2017-2022)
  • Table 219. India Drug Addiction Treatment Sales, by Addiction Type K Units (2017-2022)
  • Table 220. India Drug Addiction Treatment Sales, by Distribution Channel K Units (2017-2022)
  • Table 221. India Drug Addiction Treatment Sales, by Treatment Centers K Units (2017-2022)
  • Table 222. South Korea Drug Addiction Treatment Sales, by Type K Units (2017-2022)
  • Table 223. South Korea Drug Addiction Treatment Sales, by Application K Units (2017-2022)
  • Table 224. South Korea Drug Addiction Treatment Sales, by Addiction Type K Units (2017-2022)
  • Table 225. South Korea Drug Addiction Treatment Sales, by Distribution Channel K Units (2017-2022)
  • Table 226. South Korea Drug Addiction Treatment Sales, by Treatment Centers K Units (2017-2022)
  • Table 227. Taiwan Drug Addiction Treatment Sales, by Type K Units (2017-2022)
  • Table 228. Taiwan Drug Addiction Treatment Sales, by Application K Units (2017-2022)
  • Table 229. Taiwan Drug Addiction Treatment Sales, by Addiction Type K Units (2017-2022)
  • Table 230. Taiwan Drug Addiction Treatment Sales, by Distribution Channel K Units (2017-2022)
  • Table 231. Taiwan Drug Addiction Treatment Sales, by Treatment Centers K Units (2017-2022)
  • Table 232. Australia Drug Addiction Treatment Sales, by Type K Units (2017-2022)
  • Table 233. Australia Drug Addiction Treatment Sales, by Application K Units (2017-2022)
  • Table 234. Australia Drug Addiction Treatment Sales, by Addiction Type K Units (2017-2022)
  • Table 235. Australia Drug Addiction Treatment Sales, by Distribution Channel K Units (2017-2022)
  • Table 236. Australia Drug Addiction Treatment Sales, by Treatment Centers K Units (2017-2022)
  • Table 237. Rest of Asia-Pacific Drug Addiction Treatment Sales, by Type K Units (2017-2022)
  • Table 238. Rest of Asia-Pacific Drug Addiction Treatment Sales, by Application K Units (2017-2022)
  • Table 239. Rest of Asia-Pacific Drug Addiction Treatment Sales, by Addiction Type K Units (2017-2022)
  • Table 240. Rest of Asia-Pacific Drug Addiction Treatment Sales, by Distribution Channel K Units (2017-2022)
  • Table 241. Rest of Asia-Pacific Drug Addiction Treatment Sales, by Treatment Centers K Units (2017-2022)
  • Table 242. Europe Drug Addiction Treatment Sales, by Country K Units (2017-2022)
  • Table 243. Europe Drug Addiction Treatment Sales, by Type K Units (2017-2022)
  • Table 244. Europe Drug Addiction Treatment Sales, by Application K Units (2017-2022)
  • Table 245. Europe Drug Addiction Treatment Sales, by Addiction Type K Units (2017-2022)
  • Table 246. Europe Drug Addiction Treatment Sales, by Distribution Channel K Units (2017-2022)
  • Table 247. Europe Drug Addiction Treatment Sales, by Treatment Centers K Units (2017-2022)
  • Table 248. Germany Drug Addiction Treatment Sales, by Type K Units (2017-2022)
  • Table 249. Germany Drug Addiction Treatment Sales, by Application K Units (2017-2022)
  • Table 250. Germany Drug Addiction Treatment Sales, by Addiction Type K Units (2017-2022)
  • Table 251. Germany Drug Addiction Treatment Sales, by Distribution Channel K Units (2017-2022)
  • Table 252. Germany Drug Addiction Treatment Sales, by Treatment Centers K Units (2017-2022)
  • Table 253. France Drug Addiction Treatment Sales, by Type K Units (2017-2022)
  • Table 254. France Drug Addiction Treatment Sales, by Application K Units (2017-2022)
  • Table 255. France Drug Addiction Treatment Sales, by Addiction Type K Units (2017-2022)
  • Table 256. France Drug Addiction Treatment Sales, by Distribution Channel K Units (2017-2022)
  • Table 257. France Drug Addiction Treatment Sales, by Treatment Centers K Units (2017-2022)
  • Table 258. Italy Drug Addiction Treatment Sales, by Type K Units (2017-2022)
  • Table 259. Italy Drug Addiction Treatment Sales, by Application K Units (2017-2022)
  • Table 260. Italy Drug Addiction Treatment Sales, by Addiction Type K Units (2017-2022)
  • Table 261. Italy Drug Addiction Treatment Sales, by Distribution Channel K Units (2017-2022)
  • Table 262. Italy Drug Addiction Treatment Sales, by Treatment Centers K Units (2017-2022)
  • Table 263. United Kingdom Drug Addiction Treatment Sales, by Type K Units (2017-2022)
  • Table 264. United Kingdom Drug Addiction Treatment Sales, by Application K Units (2017-2022)
  • Table 265. United Kingdom Drug Addiction Treatment Sales, by Addiction Type K Units (2017-2022)
  • Table 266. United Kingdom Drug Addiction Treatment Sales, by Distribution Channel K Units (2017-2022)
  • Table 267. United Kingdom Drug Addiction Treatment Sales, by Treatment Centers K Units (2017-2022)
  • Table 268. Netherlands Drug Addiction Treatment Sales, by Type K Units (2017-2022)
  • Table 269. Netherlands Drug Addiction Treatment Sales, by Application K Units (2017-2022)
  • Table 270. Netherlands Drug Addiction Treatment Sales, by Addiction Type K Units (2017-2022)
  • Table 271. Netherlands Drug Addiction Treatment Sales, by Distribution Channel K Units (2017-2022)
  • Table 272. Netherlands Drug Addiction Treatment Sales, by Treatment Centers K Units (2017-2022)
  • Table 273. Rest of Europe Drug Addiction Treatment Sales, by Type K Units (2017-2022)
  • Table 274. Rest of Europe Drug Addiction Treatment Sales, by Application K Units (2017-2022)
  • Table 275. Rest of Europe Drug Addiction Treatment Sales, by Addiction Type K Units (2017-2022)
  • Table 276. Rest of Europe Drug Addiction Treatment Sales, by Distribution Channel K Units (2017-2022)
  • Table 277. Rest of Europe Drug Addiction Treatment Sales, by Treatment Centers K Units (2017-2022)
  • Table 278. MEA Drug Addiction Treatment Sales, by Country K Units (2017-2022)
  • Table 279. MEA Drug Addiction Treatment Sales, by Type K Units (2017-2022)
  • Table 280. MEA Drug Addiction Treatment Sales, by Application K Units (2017-2022)
  • Table 281. MEA Drug Addiction Treatment Sales, by Addiction Type K Units (2017-2022)
  • Table 282. MEA Drug Addiction Treatment Sales, by Distribution Channel K Units (2017-2022)
  • Table 283. MEA Drug Addiction Treatment Sales, by Treatment Centers K Units (2017-2022)
  • Table 284. Middle East Drug Addiction Treatment Sales, by Type K Units (2017-2022)
  • Table 285. Middle East Drug Addiction Treatment Sales, by Application K Units (2017-2022)
  • Table 286. Middle East Drug Addiction Treatment Sales, by Addiction Type K Units (2017-2022)
  • Table 287. Middle East Drug Addiction Treatment Sales, by Distribution Channel K Units (2017-2022)
  • Table 288. Middle East Drug Addiction Treatment Sales, by Treatment Centers K Units (2017-2022)
  • Table 289. Africa Drug Addiction Treatment Sales, by Type K Units (2017-2022)
  • Table 290. Africa Drug Addiction Treatment Sales, by Application K Units (2017-2022)
  • Table 291. Africa Drug Addiction Treatment Sales, by Addiction Type K Units (2017-2022)
  • Table 292. Africa Drug Addiction Treatment Sales, by Distribution Channel K Units (2017-2022)
  • Table 293. Africa Drug Addiction Treatment Sales, by Treatment Centers K Units (2017-2022)
  • Table 294. North America Drug Addiction Treatment Sales, by Country K Units (2017-2022)
  • Table 295. North America Drug Addiction Treatment Sales, by Type K Units (2017-2022)
  • Table 296. North America Drug Addiction Treatment Sales, by Application K Units (2017-2022)
  • Table 297. North America Drug Addiction Treatment Sales, by Addiction Type K Units (2017-2022)
  • Table 298. North America Drug Addiction Treatment Sales, by Distribution Channel K Units (2017-2022)
  • Table 299. North America Drug Addiction Treatment Sales, by Treatment Centers K Units (2017-2022)
  • Table 300. United States Drug Addiction Treatment Sales, by Type K Units (2017-2022)
  • Table 301. United States Drug Addiction Treatment Sales, by Application K Units (2017-2022)
  • Table 302. United States Drug Addiction Treatment Sales, by Addiction Type K Units (2017-2022)
  • Table 303. United States Drug Addiction Treatment Sales, by Distribution Channel K Units (2017-2022)
  • Table 304. United States Drug Addiction Treatment Sales, by Treatment Centers K Units (2017-2022)
  • Table 305. Canada Drug Addiction Treatment Sales, by Type K Units (2017-2022)
  • Table 306. Canada Drug Addiction Treatment Sales, by Application K Units (2017-2022)
  • Table 307. Canada Drug Addiction Treatment Sales, by Addiction Type K Units (2017-2022)
  • Table 308. Canada Drug Addiction Treatment Sales, by Distribution Channel K Units (2017-2022)
  • Table 309. Canada Drug Addiction Treatment Sales, by Treatment Centers K Units (2017-2022)
  • Table 310. Mexico Drug Addiction Treatment Sales, by Type K Units (2017-2022)
  • Table 311. Mexico Drug Addiction Treatment Sales, by Application K Units (2017-2022)
  • Table 312. Mexico Drug Addiction Treatment Sales, by Addiction Type K Units (2017-2022)
  • Table 313. Mexico Drug Addiction Treatment Sales, by Distribution Channel K Units (2017-2022)
  • Table 314. Mexico Drug Addiction Treatment Sales, by Treatment Centers K Units (2017-2022)
  • Table 315. Drug Addiction Treatment: by Type(USD/Units)
  • Table 316. Company Basic Information, Sales Area and Its Competitors
  • Table 317. Company Basic Information, Sales Area and Its Competitors
  • Table 318. Company Basic Information, Sales Area and Its Competitors
  • Table 319. Company Basic Information, Sales Area and Its Competitors
  • Table 320. Company Basic Information, Sales Area and Its Competitors
  • Table 321. Company Basic Information, Sales Area and Its Competitors
  • Table 322. Company Basic Information, Sales Area and Its Competitors
  • Table 323. Company Basic Information, Sales Area and Its Competitors
  • Table 324. Drug Addiction Treatment: by Type(USD Billion)
  • Table 325. Drug Addiction Treatment Methadone , by Region USD Billion (2023-2028)
  • Table 326. Drug Addiction Treatment Buprenorphine , by Region USD Billion (2023-2028)
  • Table 327. Drug Addiction Treatment Naltrexone , by Region USD Billion (2023-2028)
  • Table 328. Drug Addiction Treatment Bupropion , by Region USD Billion (2023-2028)
  • Table 329. Drug Addiction Treatment Varenicline , by Region USD Billion (2023-2028)
  • Table 330. Drug Addiction Treatment Others , by Region USD Billion (2023-2028)
  • Table 331. Drug Addiction Treatment: by Application(USD Billion)
  • Table 332. Drug Addiction Treatment Hospitals , by Region USD Billion (2023-2028)
  • Table 333. Drug Addiction Treatment Clinics , by Region USD Billion (2023-2028)
  • Table 334. Drug Addiction Treatment: by Addiction Type(USD Billion)
  • Table 335. Drug Addiction Treatment Opioid Addiction , by Region USD Billion (2023-2028)
  • Table 336. Drug Addiction Treatment Tobacco/Nicotine Addiction , by Region USD Billion (2023-2028)
  • Table 337. Drug Addiction Treatment Alcohol Dependence , by Region USD Billion (2023-2028)
  • Table 338. Drug Addiction Treatment: by Distribution Channel(USD Billion)
  • Table 339. Drug Addiction Treatment Hospital Pharmacy , by Region USD Billion (2023-2028)
  • Table 340. Drug Addiction Treatment Retail Pharmacy , by Region USD Billion (2023-2028)
  • Table 341. Drug Addiction Treatment Online Pharmacy , by Region USD Billion (2023-2028)
  • Table 342. Drug Addiction Treatment: by Treatment Centers(USD Billion)
  • Table 343. Drug Addiction Treatment Outpatient Treatment Centers , by Region USD Billion (2023-2028)
  • Table 344. Drug Addiction Treatment Residential Treatment Centers , by Region USD Billion (2023-2028)
  • Table 345. Drug Addiction Treatment Inpatient Treatment Centers , by Region USD Billion (2023-2028)
  • Table 346. South America Drug Addiction Treatment, by Country USD Billion (2023-2028)
  • Table 347. South America Drug Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 348. South America Drug Addiction Treatment, by Application USD Billion (2023-2028)
  • Table 349. South America Drug Addiction Treatment, by Addiction Type USD Billion (2023-2028)
  • Table 350. South America Drug Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 351. South America Drug Addiction Treatment, by Treatment Centers USD Billion (2023-2028)
  • Table 352. Brazil Drug Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 353. Brazil Drug Addiction Treatment, by Application USD Billion (2023-2028)
  • Table 354. Brazil Drug Addiction Treatment, by Addiction Type USD Billion (2023-2028)
  • Table 355. Brazil Drug Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 356. Brazil Drug Addiction Treatment, by Treatment Centers USD Billion (2023-2028)
  • Table 357. Argentina Drug Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 358. Argentina Drug Addiction Treatment, by Application USD Billion (2023-2028)
  • Table 359. Argentina Drug Addiction Treatment, by Addiction Type USD Billion (2023-2028)
  • Table 360. Argentina Drug Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 361. Argentina Drug Addiction Treatment, by Treatment Centers USD Billion (2023-2028)
  • Table 362. Rest of South America Drug Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 363. Rest of South America Drug Addiction Treatment, by Application USD Billion (2023-2028)
  • Table 364. Rest of South America Drug Addiction Treatment, by Addiction Type USD Billion (2023-2028)
  • Table 365. Rest of South America Drug Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 366. Rest of South America Drug Addiction Treatment, by Treatment Centers USD Billion (2023-2028)
  • Table 367. Asia Pacific Drug Addiction Treatment, by Country USD Billion (2023-2028)
  • Table 368. Asia Pacific Drug Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 369. Asia Pacific Drug Addiction Treatment, by Application USD Billion (2023-2028)
  • Table 370. Asia Pacific Drug Addiction Treatment, by Addiction Type USD Billion (2023-2028)
  • Table 371. Asia Pacific Drug Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 372. Asia Pacific Drug Addiction Treatment, by Treatment Centers USD Billion (2023-2028)
  • Table 373. China Drug Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 374. China Drug Addiction Treatment, by Application USD Billion (2023-2028)
  • Table 375. China Drug Addiction Treatment, by Addiction Type USD Billion (2023-2028)
  • Table 376. China Drug Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 377. China Drug Addiction Treatment, by Treatment Centers USD Billion (2023-2028)
  • Table 378. Japan Drug Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 379. Japan Drug Addiction Treatment, by Application USD Billion (2023-2028)
  • Table 380. Japan Drug Addiction Treatment, by Addiction Type USD Billion (2023-2028)
  • Table 381. Japan Drug Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 382. Japan Drug Addiction Treatment, by Treatment Centers USD Billion (2023-2028)
  • Table 383. India Drug Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 384. India Drug Addiction Treatment, by Application USD Billion (2023-2028)
  • Table 385. India Drug Addiction Treatment, by Addiction Type USD Billion (2023-2028)
  • Table 386. India Drug Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 387. India Drug Addiction Treatment, by Treatment Centers USD Billion (2023-2028)
  • Table 388. South Korea Drug Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 389. South Korea Drug Addiction Treatment, by Application USD Billion (2023-2028)
  • Table 390. South Korea Drug Addiction Treatment, by Addiction Type USD Billion (2023-2028)
  • Table 391. South Korea Drug Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 392. South Korea Drug Addiction Treatment, by Treatment Centers USD Billion (2023-2028)
  • Table 393. Taiwan Drug Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 394. Taiwan Drug Addiction Treatment, by Application USD Billion (2023-2028)
  • Table 395. Taiwan Drug Addiction Treatment, by Addiction Type USD Billion (2023-2028)
  • Table 396. Taiwan Drug Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 397. Taiwan Drug Addiction Treatment, by Treatment Centers USD Billion (2023-2028)
  • Table 398. Australia Drug Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 399. Australia Drug Addiction Treatment, by Application USD Billion (2023-2028)
  • Table 400. Australia Drug Addiction Treatment, by Addiction Type USD Billion (2023-2028)
  • Table 401. Australia Drug Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 402. Australia Drug Addiction Treatment, by Treatment Centers USD Billion (2023-2028)
  • Table 403. Rest of Asia-Pacific Drug Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 404. Rest of Asia-Pacific Drug Addiction Treatment, by Application USD Billion (2023-2028)
  • Table 405. Rest of Asia-Pacific Drug Addiction Treatment, by Addiction Type USD Billion (2023-2028)
  • Table 406. Rest of Asia-Pacific Drug Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 407. Rest of Asia-Pacific Drug Addiction Treatment, by Treatment Centers USD Billion (2023-2028)
  • Table 408. Europe Drug Addiction Treatment, by Country USD Billion (2023-2028)
  • Table 409. Europe Drug Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 410. Europe Drug Addiction Treatment, by Application USD Billion (2023-2028)
  • Table 411. Europe Drug Addiction Treatment, by Addiction Type USD Billion (2023-2028)
  • Table 412. Europe Drug Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 413. Europe Drug Addiction Treatment, by Treatment Centers USD Billion (2023-2028)
  • Table 414. Germany Drug Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 415. Germany Drug Addiction Treatment, by Application USD Billion (2023-2028)
  • Table 416. Germany Drug Addiction Treatment, by Addiction Type USD Billion (2023-2028)
  • Table 417. Germany Drug Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 418. Germany Drug Addiction Treatment, by Treatment Centers USD Billion (2023-2028)
  • Table 419. France Drug Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 420. France Drug Addiction Treatment, by Application USD Billion (2023-2028)
  • Table 421. France Drug Addiction Treatment, by Addiction Type USD Billion (2023-2028)
  • Table 422. France Drug Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 423. France Drug Addiction Treatment, by Treatment Centers USD Billion (2023-2028)
  • Table 424. Italy Drug Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 425. Italy Drug Addiction Treatment, by Application USD Billion (2023-2028)
  • Table 426. Italy Drug Addiction Treatment, by Addiction Type USD Billion (2023-2028)
  • Table 427. Italy Drug Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 428. Italy Drug Addiction Treatment, by Treatment Centers USD Billion (2023-2028)
  • Table 429. United Kingdom Drug Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 430. United Kingdom Drug Addiction Treatment, by Application USD Billion (2023-2028)
  • Table 431. United Kingdom Drug Addiction Treatment, by Addiction Type USD Billion (2023-2028)
  • Table 432. United Kingdom Drug Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 433. United Kingdom Drug Addiction Treatment, by Treatment Centers USD Billion (2023-2028)
  • Table 434. Netherlands Drug Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 435. Netherlands Drug Addiction Treatment, by Application USD Billion (2023-2028)
  • Table 436. Netherlands Drug Addiction Treatment, by Addiction Type USD Billion (2023-2028)
  • Table 437. Netherlands Drug Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 438. Netherlands Drug Addiction Treatment, by Treatment Centers USD Billion (2023-2028)
  • Table 439. Rest of Europe Drug Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 440. Rest of Europe Drug Addiction Treatment, by Application USD Billion (2023-2028)
  • Table 441. Rest of Europe Drug Addiction Treatment, by Addiction Type USD Billion (2023-2028)
  • Table 442. Rest of Europe Drug Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 443. Rest of Europe Drug Addiction Treatment, by Treatment Centers USD Billion (2023-2028)
  • Table 444. MEA Drug Addiction Treatment, by Country USD Billion (2023-2028)
  • Table 445. MEA Drug Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 446. MEA Drug Addiction Treatment, by Application USD Billion (2023-2028)
  • Table 447. MEA Drug Addiction Treatment, by Addiction Type USD Billion (2023-2028)
  • Table 448. MEA Drug Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 449. MEA Drug Addiction Treatment, by Treatment Centers USD Billion (2023-2028)
  • Table 450. Middle East Drug Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 451. Middle East Drug Addiction Treatment, by Application USD Billion (2023-2028)
  • Table 452. Middle East Drug Addiction Treatment, by Addiction Type USD Billion (2023-2028)
  • Table 453. Middle East Drug Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 454. Middle East Drug Addiction Treatment, by Treatment Centers USD Billion (2023-2028)
  • Table 455. Africa Drug Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 456. Africa Drug Addiction Treatment, by Application USD Billion (2023-2028)
  • Table 457. Africa Drug Addiction Treatment, by Addiction Type USD Billion (2023-2028)
  • Table 458. Africa Drug Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 459. Africa Drug Addiction Treatment, by Treatment Centers USD Billion (2023-2028)
  • Table 460. North America Drug Addiction Treatment, by Country USD Billion (2023-2028)
  • Table 461. North America Drug Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 462. North America Drug Addiction Treatment, by Application USD Billion (2023-2028)
  • Table 463. North America Drug Addiction Treatment, by Addiction Type USD Billion (2023-2028)
  • Table 464. North America Drug Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 465. North America Drug Addiction Treatment, by Treatment Centers USD Billion (2023-2028)
  • Table 466. United States Drug Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 467. United States Drug Addiction Treatment, by Application USD Billion (2023-2028)
  • Table 468. United States Drug Addiction Treatment, by Addiction Type USD Billion (2023-2028)
  • Table 469. United States Drug Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 470. United States Drug Addiction Treatment, by Treatment Centers USD Billion (2023-2028)
  • Table 471. Canada Drug Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 472. Canada Drug Addiction Treatment, by Application USD Billion (2023-2028)
  • Table 473. Canada Drug Addiction Treatment, by Addiction Type USD Billion (2023-2028)
  • Table 474. Canada Drug Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 475. Canada Drug Addiction Treatment, by Treatment Centers USD Billion (2023-2028)
  • Table 476. Mexico Drug Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 477. Mexico Drug Addiction Treatment, by Application USD Billion (2023-2028)
  • Table 478. Mexico Drug Addiction Treatment, by Addiction Type USD Billion (2023-2028)
  • Table 479. Mexico Drug Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 480. Mexico Drug Addiction Treatment, by Treatment Centers USD Billion (2023-2028)
  • Table 481. Drug Addiction Treatment Sales: by Type(K Units)
  • Table 482. Drug Addiction Treatment Sales Methadone , by Region K Units (2023-2028)
  • Table 483. Drug Addiction Treatment Sales Buprenorphine , by Region K Units (2023-2028)
  • Table 484. Drug Addiction Treatment Sales Naltrexone , by Region K Units (2023-2028)
  • Table 485. Drug Addiction Treatment Sales Bupropion , by Region K Units (2023-2028)
  • Table 486. Drug Addiction Treatment Sales Varenicline , by Region K Units (2023-2028)
  • Table 487. Drug Addiction Treatment Sales Others , by Region K Units (2023-2028)
  • Table 488. Drug Addiction Treatment Sales: by Application(K Units)
  • Table 489. Drug Addiction Treatment Sales Hospitals , by Region K Units (2023-2028)
  • Table 490. Drug Addiction Treatment Sales Clinics , by Region K Units (2023-2028)
  • Table 491. Drug Addiction Treatment Sales: by Addiction Type(K Units)
  • Table 492. Drug Addiction Treatment Sales Opioid Addiction , by Region K Units (2023-2028)
  • Table 493. Drug Addiction Treatment Sales Tobacco/Nicotine Addiction , by Region K Units (2023-2028)
  • Table 494. Drug Addiction Treatment Sales Alcohol Dependence , by Region K Units (2023-2028)
  • Table 495. Drug Addiction Treatment Sales: by Distribution Channel(K Units)
  • Table 496. Drug Addiction Treatment Sales Hospital Pharmacy , by Region K Units (2023-2028)
  • Table 497. Drug Addiction Treatment Sales Retail Pharmacy , by Region K Units (2023-2028)
  • Table 498. Drug Addiction Treatment Sales Online Pharmacy , by Region K Units (2023-2028)
  • Table 499. Drug Addiction Treatment Sales: by Treatment Centers(K Units)
  • Table 500. Drug Addiction Treatment Sales Outpatient Treatment Centers , by Region K Units (2023-2028)
  • Table 501. Drug Addiction Treatment Sales Residential Treatment Centers , by Region K Units (2023-2028)
  • Table 502. Drug Addiction Treatment Sales Inpatient Treatment Centers , by Region K Units (2023-2028)
  • Table 503. South America Drug Addiction Treatment Sales, by Country K Units (2023-2028)
  • Table 504. South America Drug Addiction Treatment Sales, by Type K Units (2023-2028)
  • Table 505. South America Drug Addiction Treatment Sales, by Application K Units (2023-2028)
  • Table 506. South America Drug Addiction Treatment Sales, by Addiction Type K Units (2023-2028)
  • Table 507. South America Drug Addiction Treatment Sales, by Distribution Channel K Units (2023-2028)
  • Table 508. South America Drug Addiction Treatment Sales, by Treatment Centers K Units (2023-2028)
  • Table 509. Brazil Drug Addiction Treatment Sales, by Type K Units (2023-2028)
  • Table 510. Brazil Drug Addiction Treatment Sales, by Application K Units (2023-2028)
  • Table 511. Brazil Drug Addiction Treatment Sales, by Addiction Type K Units (2023-2028)
  • Table 512. Brazil Drug Addiction Treatment Sales, by Distribution Channel K Units (2023-2028)
  • Table 513. Brazil Drug Addiction Treatment Sales, by Treatment Centers K Units (2023-2028)
  • Table 514. Argentina Drug Addiction Treatment Sales, by Type K Units (2023-2028)
  • Table 515. Argentina Drug Addiction Treatment Sales, by Application K Units (2023-2028)
  • Table 516. Argentina Drug Addiction Treatment Sales, by Addiction Type K Units (2023-2028)
  • Table 517. Argentina Drug Addiction Treatment Sales, by Distribution Channel K Units (2023-2028)
  • Table 518. Argentina Drug Addiction Treatment Sales, by Treatment Centers K Units (2023-2028)
  • Table 519. Rest of South America Drug Addiction Treatment Sales, by Type K Units (2023-2028)
  • Table 520. Rest of South America Drug Addiction Treatment Sales, by Application K Units (2023-2028)
  • Table 521. Rest of South America Drug Addiction Treatment Sales, by Addiction Type K Units (2023-2028)
  • Table 522. Rest of South America Drug Addiction Treatment Sales, by Distribution Channel K Units (2023-2028)
  • Table 523. Rest of South America Drug Addiction Treatment Sales, by Treatment Centers K Units (2023-2028)
  • Table 524. Asia Pacific Drug Addiction Treatment Sales, by Country K Units (2023-2028)
  • Table 525. Asia Pacific Drug Addiction Treatment Sales, by Type K Units (2023-2028)
  • Table 526. Asia Pacific Drug Addiction Treatment Sales, by Application K Units (2023-2028)
  • Table 527. Asia Pacific Drug Addiction Treatment Sales, by Addiction Type K Units (2023-2028)
  • Table 528. Asia Pacific Drug Addiction Treatment Sales, by Distribution Channel K Units (2023-2028)
  • Table 529. Asia Pacific Drug Addiction Treatment Sales, by Treatment Centers K Units (2023-2028)
  • Table 530. China Drug Addiction Treatment Sales, by Type K Units (2023-2028)
  • Table 531. China Drug Addiction Treatment Sales, by Application K Units (2023-2028)
  • Table 532. China Drug Addiction Treatment Sales, by Addiction Type K Units (2023-2028)
  • Table 533. China Drug Addiction Treatment Sales, by Distribution Channel K Units (2023-2028)
  • Table 534. China Drug Addiction Treatment Sales, by Treatment Centers K Units (2023-2028)
  • Table 535. Japan Drug Addiction Treatment Sales, by Type K Units (2023-2028)
  • Table 536. Japan Drug Addiction Treatment Sales, by Application K Units (2023-2028)
  • Table 537. Japan Drug Addiction Treatment Sales, by Addiction Type K Units (2023-2028)
  • Table 538. Japan Drug Addiction Treatment Sales, by Distribution Channel K Units (2023-2028)
  • Table 539. Japan Drug Addiction Treatment Sales, by Treatment Centers K Units (2023-2028)
  • Table 540. India Drug Addiction Treatment Sales, by Type K Units (2023-2028)
  • Table 541. India Drug Addiction Treatment Sales, by Application K Units (2023-2028)
  • Table 542. India Drug Addiction Treatment Sales, by Addiction Type K Units (2023-2028)
  • Table 543. India Drug Addiction Treatment Sales, by Distribution Channel K Units (2023-2028)
  • Table 544. India Drug Addiction Treatment Sales, by Treatment Centers K Units (2023-2028)
  • Table 545. South Korea Drug Addiction Treatment Sales, by Type K Units (2023-2028)
  • Table 546. South Korea Drug Addiction Treatment Sales, by Application K Units (2023-2028)
  • Table 547. South Korea Drug Addiction Treatment Sales, by Addiction Type K Units (2023-2028)
  • Table 548. South Korea Drug Addiction Treatment Sales, by Distribution Channel K Units (2023-2028)
  • Table 549. South Korea Drug Addiction Treatment Sales, by Treatment Centers K Units (2023-2028)
  • Table 550. Taiwan Drug Addiction Treatment Sales, by Type K Units (2023-2028)
  • Table 551. Taiwan Drug Addiction Treatment Sales, by Application K Units (2023-2028)
  • Table 552. Taiwan Drug Addiction Treatment Sales, by Addiction Type K Units (2023-2028)
  • Table 553. Taiwan Drug Addiction Treatment Sales, by Distribution Channel K Units (2023-2028)
  • Table 554. Taiwan Drug Addiction Treatment Sales, by Treatment Centers K Units (2023-2028)
  • Table 555. Australia Drug Addiction Treatment Sales, by Type K Units (2023-2028)
  • Table 556. Australia Drug Addiction Treatment Sales, by Application K Units (2023-2028)
  • Table 557. Australia Drug Addiction Treatment Sales, by Addiction Type K Units (2023-2028)
  • Table 558. Australia Drug Addiction Treatment Sales, by Distribution Channel K Units (2023-2028)
  • Table 559. Australia Drug Addiction Treatment Sales, by Treatment Centers K Units (2023-2028)
  • Table 560. Rest of Asia-Pacific Drug Addiction Treatment Sales, by Type K Units (2023-2028)
  • Table 561. Rest of Asia-Pacific Drug Addiction Treatment Sales, by Application K Units (2023-2028)
  • Table 562. Rest of Asia-Pacific Drug Addiction Treatment Sales, by Addiction Type K Units (2023-2028)
  • Table 563. Rest of Asia-Pacific Drug Addiction Treatment Sales, by Distribution Channel K Units (2023-2028)
  • Table 564. Rest of Asia-Pacific Drug Addiction Treatment Sales, by Treatment Centers K Units (2023-2028)
  • Table 565. Europe Drug Addiction Treatment Sales, by Country K Units (2023-2028)
  • Table 566. Europe Drug Addiction Treatment Sales, by Type K Units (2023-2028)
  • Table 567. Europe Drug Addiction Treatment Sales, by Application K Units (2023-2028)
  • Table 568. Europe Drug Addiction Treatment Sales, by Addiction Type K Units (2023-2028)
  • Table 569. Europe Drug Addiction Treatment Sales, by Distribution Channel K Units (2023-2028)
  • Table 570. Europe Drug Addiction Treatment Sales, by Treatment Centers K Units (2023-2028)
  • Table 571. Germany Drug Addiction Treatment Sales, by Type K Units (2023-2028)
  • Table 572. Germany Drug Addiction Treatment Sales, by Application K Units (2023-2028)
  • Table 573. Germany Drug Addiction Treatment Sales, by Addiction Type K Units (2023-2028)
  • Table 574. Germany Drug Addiction Treatment Sales, by Distribution Channel K Units (2023-2028)
  • Table 575. Germany Drug Addiction Treatment Sales, by Treatment Centers K Units (2023-2028)
  • Table 576. France Drug Addiction Treatment Sales, by Type K Units (2023-2028)
  • Table 577. France Drug Addiction Treatment Sales, by Application K Units (2023-2028)
  • Table 578. France Drug Addiction Treatment Sales, by Addiction Type K Units (2023-2028)
  • Table 579. France Drug Addiction Treatment Sales, by Distribution Channel K Units (2023-2028)
  • Table 580. France Drug Addiction Treatment Sales, by Treatment Centers K Units (2023-2028)
  • Table 581. Italy Drug Addiction Treatment Sales, by Type K Units (2023-2028)
  • Table 582. Italy Drug Addiction Treatment Sales, by Application K Units (2023-2028)
  • Table 583. Italy Drug Addiction Treatment Sales, by Addiction Type K Units (2023-2028)
  • Table 584. Italy Drug Addiction Treatment Sales, by Distribution Channel K Units (2023-2028)
  • Table 585. Italy Drug Addiction Treatment Sales, by Treatment Centers K Units (2023-2028)
  • Table 586. United Kingdom Drug Addiction Treatment Sales, by Type K Units (2023-2028)
  • Table 587. United Kingdom Drug Addiction Treatment Sales, by Application K Units (2023-2028)
  • Table 588. United Kingdom Drug Addiction Treatment Sales, by Addiction Type K Units (2023-2028)
  • Table 589. United Kingdom Drug Addiction Treatment Sales, by Distribution Channel K Units (2023-2028)
  • Table 590. United Kingdom Drug Addiction Treatment Sales, by Treatment Centers K Units (2023-2028)
  • Table 591. Netherlands Drug Addiction Treatment Sales, by Type K Units (2023-2028)
  • Table 592. Netherlands Drug Addiction Treatment Sales, by Application K Units (2023-2028)
  • Table 593. Netherlands Drug Addiction Treatment Sales, by Addiction Type K Units (2023-2028)
  • Table 594. Netherlands Drug Addiction Treatment Sales, by Distribution Channel K Units (2023-2028)
  • Table 595. Netherlands Drug Addiction Treatment Sales, by Treatment Centers K Units (2023-2028)
  • Table 596. Rest of Europe Drug Addiction Treatment Sales, by Type K Units (2023-2028)
  • Table 597. Rest of Europe Drug Addiction Treatment Sales, by Application K Units (2023-2028)
  • Table 598. Rest of Europe Drug Addiction Treatment Sales, by Addiction Type K Units (2023-2028)
  • Table 599. Rest of Europe Drug Addiction Treatment Sales, by Distribution Channel K Units (2023-2028)
  • Table 600. Rest of Europe Drug Addiction Treatment Sales, by Treatment Centers K Units (2023-2028)
  • Table 601. MEA Drug Addiction Treatment Sales, by Country K Units (2023-2028)
  • Table 602. MEA Drug Addiction Treatment Sales, by Type K Units (2023-2028)
  • Table 603. MEA Drug Addiction Treatment Sales, by Application K Units (2023-2028)
  • Table 604. MEA Drug Addiction Treatment Sales, by Addiction Type K Units (2023-2028)
  • Table 605. MEA Drug Addiction Treatment Sales, by Distribution Channel K Units (2023-2028)
  • Table 606. MEA Drug Addiction Treatment Sales, by Treatment Centers K Units (2023-2028)
  • Table 607. Middle East Drug Addiction Treatment Sales, by Type K Units (2023-2028)
  • Table 608. Middle East Drug Addiction Treatment Sales, by Application K Units (2023-2028)
  • Table 609. Middle East Drug Addiction Treatment Sales, by Addiction Type K Units (2023-2028)
  • Table 610. Middle East Drug Addiction Treatment Sales, by Distribution Channel K Units (2023-2028)
  • Table 611. Middle East Drug Addiction Treatment Sales, by Treatment Centers K Units (2023-2028)
  • Table 612. Africa Drug Addiction Treatment Sales, by Type K Units (2023-2028)
  • Table 613. Africa Drug Addiction Treatment Sales, by Application K Units (2023-2028)
  • Table 614. Africa Drug Addiction Treatment Sales, by Addiction Type K Units (2023-2028)
  • Table 615. Africa Drug Addiction Treatment Sales, by Distribution Channel K Units (2023-2028)
  • Table 616. Africa Drug Addiction Treatment Sales, by Treatment Centers K Units (2023-2028)
  • Table 617. North America Drug Addiction Treatment Sales, by Country K Units (2023-2028)
  • Table 618. North America Drug Addiction Treatment Sales, by Type K Units (2023-2028)
  • Table 619. North America Drug Addiction Treatment Sales, by Application K Units (2023-2028)
  • Table 620. North America Drug Addiction Treatment Sales, by Addiction Type K Units (2023-2028)
  • Table 621. North America Drug Addiction Treatment Sales, by Distribution Channel K Units (2023-2028)
  • Table 622. North America Drug Addiction Treatment Sales, by Treatment Centers K Units (2023-2028)
  • Table 623. United States Drug Addiction Treatment Sales, by Type K Units (2023-2028)
  • Table 624. United States Drug Addiction Treatment Sales, by Application K Units (2023-2028)
  • Table 625. United States Drug Addiction Treatment Sales, by Addiction Type K Units (2023-2028)
  • Table 626. United States Drug Addiction Treatment Sales, by Distribution Channel K Units (2023-2028)
  • Table 627. United States Drug Addiction Treatment Sales, by Treatment Centers K Units (2023-2028)
  • Table 628. Canada Drug Addiction Treatment Sales, by Type K Units (2023-2028)
  • Table 629. Canada Drug Addiction Treatment Sales, by Application K Units (2023-2028)
  • Table 630. Canada Drug Addiction Treatment Sales, by Addiction Type K Units (2023-2028)
  • Table 631. Canada Drug Addiction Treatment Sales, by Distribution Channel K Units (2023-2028)
  • Table 632. Canada Drug Addiction Treatment Sales, by Treatment Centers K Units (2023-2028)
  • Table 633. Mexico Drug Addiction Treatment Sales, by Type K Units (2023-2028)
  • Table 634. Mexico Drug Addiction Treatment Sales, by Application K Units (2023-2028)
  • Table 635. Mexico Drug Addiction Treatment Sales, by Addiction Type K Units (2023-2028)
  • Table 636. Mexico Drug Addiction Treatment Sales, by Distribution Channel K Units (2023-2028)
  • Table 637. Mexico Drug Addiction Treatment Sales, by Treatment Centers K Units (2023-2028)
  • Table 638. Drug Addiction Treatment: by Type(USD/Units)
  • Table 639. Research Programs/Design for This Report
  • Table 640. Key Data Information from Secondary Sources
  • Table 641. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Drug Addiction Treatment: by Type USD Billion (2017-2022)
  • Figure 5. Global Drug Addiction Treatment: by Application USD Billion (2017-2022)
  • Figure 6. Global Drug Addiction Treatment: by Addiction Type USD Billion (2017-2022)
  • Figure 7. Global Drug Addiction Treatment: by Distribution Channel USD Billion (2017-2022)
  • Figure 8. Global Drug Addiction Treatment: by Treatment Centers USD Billion (2017-2022)
  • Figure 9. South America Drug Addiction Treatment Share (%), by Country
  • Figure 10. Asia Pacific Drug Addiction Treatment Share (%), by Country
  • Figure 11. Europe Drug Addiction Treatment Share (%), by Country
  • Figure 12. MEA Drug Addiction Treatment Share (%), by Country
  • Figure 13. North America Drug Addiction Treatment Share (%), by Country
  • Figure 14. Global Drug Addiction Treatment: by Type K Units (2017-2022)
  • Figure 15. Global Drug Addiction Treatment: by Application K Units (2017-2022)
  • Figure 16. Global Drug Addiction Treatment: by Addiction Type K Units (2017-2022)
  • Figure 17. Global Drug Addiction Treatment: by Distribution Channel K Units (2017-2022)
  • Figure 18. Global Drug Addiction Treatment: by Treatment Centers K Units (2017-2022)
  • Figure 19. South America Drug Addiction Treatment Share (%), by Country
  • Figure 20. Asia Pacific Drug Addiction Treatment Share (%), by Country
  • Figure 21. Europe Drug Addiction Treatment Share (%), by Country
  • Figure 22. MEA Drug Addiction Treatment Share (%), by Country
  • Figure 23. North America Drug Addiction Treatment Share (%), by Country
  • Figure 24. Global Drug Addiction Treatment: by Type USD/Units (2017-2022)
  • Figure 25. Global Drug Addiction Treatment share by Players 2022 (%)
  • Figure 26. Global Drug Addiction Treatment share by Players (Top 3) 2022(%)
  • Figure 27. Global Drug Addiction Treatment share by Players (Top 5) 2022(%)
  • Figure 28. BCG Matrix for key Companies
  • Figure 29. Indivior (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 30. Indivior (United Kingdom) Revenue: by Geography 2022
  • Figure 31. Pfizer, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Pfizer, Inc. (United States) Revenue: by Geography 2022
  • Figure 33. Alkermes (Ireland) Revenue, Net Income and Gross profit
  • Figure 34. Alkermes (Ireland) Revenue: by Geography 2022
  • Figure 35. Novartis International AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 36. Novartis International AG (Switzerland) Revenue: by Geography 2022
  • Figure 37. Mylan N.V. (United States) Revenue, Net Income and Gross profit
  • Figure 38. Mylan N.V. (United States) Revenue: by Geography 2022
  • Figure 39. Cipla (India) Revenue, Net Income and Gross profit
  • Figure 40. Cipla (India) Revenue: by Geography 2022
  • Figure 41. Glenmark (India) Revenue, Net Income and Gross profit
  • Figure 42. Glenmark (India) Revenue: by Geography 2022
  • Figure 43. British American Tobacco plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 44. British American Tobacco plc (United Kingdom) Revenue: by Geography 2022
  • Figure 45. Global Drug Addiction Treatment: by Type USD Billion (2023-2028)
  • Figure 46. Global Drug Addiction Treatment: by Application USD Billion (2023-2028)
  • Figure 47. Global Drug Addiction Treatment: by Addiction Type USD Billion (2023-2028)
  • Figure 48. Global Drug Addiction Treatment: by Distribution Channel USD Billion (2023-2028)
  • Figure 49. Global Drug Addiction Treatment: by Treatment Centers USD Billion (2023-2028)
  • Figure 50. South America Drug Addiction Treatment Share (%), by Country
  • Figure 51. Asia Pacific Drug Addiction Treatment Share (%), by Country
  • Figure 52. Europe Drug Addiction Treatment Share (%), by Country
  • Figure 53. MEA Drug Addiction Treatment Share (%), by Country
  • Figure 54. North America Drug Addiction Treatment Share (%), by Country
  • Figure 55. Global Drug Addiction Treatment: by Type K Units (2023-2028)
  • Figure 56. Global Drug Addiction Treatment: by Application K Units (2023-2028)
  • Figure 57. Global Drug Addiction Treatment: by Addiction Type K Units (2023-2028)
  • Figure 58. Global Drug Addiction Treatment: by Distribution Channel K Units (2023-2028)
  • Figure 59. Global Drug Addiction Treatment: by Treatment Centers K Units (2023-2028)
  • Figure 60. South America Drug Addiction Treatment Share (%), by Country
  • Figure 61. Asia Pacific Drug Addiction Treatment Share (%), by Country
  • Figure 62. Europe Drug Addiction Treatment Share (%), by Country
  • Figure 63. MEA Drug Addiction Treatment Share (%), by Country
  • Figure 64. North America Drug Addiction Treatment Share (%), by Country
  • Figure 65. Global Drug Addiction Treatment: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Indivior (United Kingdom)
  • Pfizer, Inc. (United States)
  • Alkermes (Ireland)
  • Novartis International AG (Switzerland)
  • Mylan N.V. (United States)
  • Cipla (India)
  • Glenmark (India)
  • British American Tobacco plc (United Kingdom)
Additional players considered in the study are as follows:
Dr. Reddy's Laboratories (India) , Teva Pharmaceuticals (Israel) , PLIVA (Odyssey) (United States) , Lil Drug Store plc (United States)
Select User Access Type

Key Highlights of Report


Dec 2023 209 Pages 96 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Drug Addiction Treatment Market Quantitative research analysis
Global Drug Addiction Treatment Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Indivior (United Kingdom), Pfizer, Inc. (United States), Alkermes (Ireland), Novartis International AG (Switzerland), Mylan N.V. (United States), Cipla (India), Glenmark (India) and British American Tobacco plc (United Kingdom) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Launch and Approval of Novel Drug for the Treatment " is seen as one of major influencing trends for Drug Addiction Treatment Market during projected period 2022-2028.
The Drug Addiction Treatment market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Drug Addiction Treatment Market Report?

Have a Query? Click Here

Other Related Reports

Allergy Skin Test Comprehensive Study by Type (Scratch, Intradermal, Patch), Application (Hospitals And Clinics, Diagnostics Centers), Indication (Allergic Rhinitis, Allergic Asthma, Drug Allergy, Fo...
$ 3500
Ambulatory EHR Comprehensive Study by Application (Practice Management, Patient Management, E-Prescribing, Referral Management, Population Health Management, Decision Support, Health Analytics), Depl...
$ 3750
Diabetes Treatment Comprehensive Study by Diabetes Type (Type 1 Diabetes, Type 2 Diabetes), Device Type (Blood Glucose Monitoring Device (Testing Strips, Self-monitoring Blood Glucose Meters, Lancets...
$ 3750
Medical Device Cleaning Services Comprehensive Study by Type (Manual Cleaning, Automatic Cleaning), Application (Hospitals, Clinics, Diagnostic Centers, Other), Process (Cleaning, Disinfecting, Steri...
$ 3500
Wound Irrigation Solution Comprehensive Study by Type (Wetting Agents, Antiseptics, Others), Distribution Channel (Online, Offline), End User (Hospitals, Ambulatory Surgical Centers, Clinics, Long Te...
$ 3350
Specialty Hospitals Comprehensive Study by Type (Cancer Hospitals, Cardiac Hospitals, Rehabilitation Hospitals, ENT Hospitals, Neurology Hospitals, Orthopedic Hospitals, Others), Application (Men, Wo...
$ 3750